| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2012 | Cancer Immunotherapy Using a Membrane-bound Interleukin-12 With B7-1 Transmembrane and Cytoplasmic Domains. | an, WY; Lo, CH; Chen, CC; Wu, PY; Roffler, SR; Shyue, SK; Tao, MH | MOLECULAR THERAPY 20(5), 927-937 | | | |
| 2013 | Characterization of Neuroblastic Tumors Using 18F-FDOPA PET | Lu, MY; Liu, YL; Chang, HH; Jou, ST; Yang, YL; Lin, KH; Lin, DT; Lee, YL; Lee, H; Wu, PY; Luo, TY; Shen, LH; Huang, SF; Liao, YF; Hsu, WM; Tzen, KY | JOURNAL OF NUCLEAR MEDICINE 54, 42–49 | | | |
| 2023 | Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants | Sun, CP ; Chiu, CW; Wu, PY; Tsung, SI; Lee, IJ; Hu, CW; Hsu, MF; Kuo, TJ; Lan, YH; Chen, LY; Ng, HY; Chung, MJ; Liao, HN; Tseng, SC; Lo, CH; Chen, YJ; Liao, CC ; Chang, CS; Liang, JJ; Draczkowski, P; Puri, S; Chang, YC ; Huang, JS; Chen, CC; Kau, JH; Chen, YH ; Liu, WC ; Wu, HC ; Hsu, STD ; Wang, IH ; Tao, MH | Molecular Therapy 31(11), 3322-3336 | | | |
| 2020 | Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects | Cheng, YW; Chao, TL; Li, CL; Chiu, MF; Kao, HC; Wang, SH; Pang, YH; Lin, CH; Tsai, YM; Lee, WH; Tao, MH ; Ho, TC; Wu, PY; Jang, LT; Chen, PJ; Chang, SY; Yeh, SH | CELL REPORTS 33(2), 108254 | | | |
| 2012 | Intermolecular Binding between TIFA-FHA and TIFA-pT Mediates Tumor Necrosis Factor Alpha Stimulation and NF-κB Activation | Huang, CC; Weng, JH; Wei, TY; Wu, PY; Hsu, PH; Chen, YH; Wang, SC; Qin, D; Hung, CC ; Chen, ST ; Wang, AH ; Shyy, JY; Tsai, MD | Molecular and cellular biology 32(14), 2664-2673 | | | |
| 2022 | Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants | Lee, IJ; Sun, CP; Wu, PY; Lan, YH; Wang, IH ; Liu, WC ; Tseng, SC; Tsung, SI; Chou, YC ; Kumari, M; Chang, YW; Chen, HF; Lin, YS; Chen, TY; Chiu, CW; Hsieh, CH; Chuang, CY; Lin, CC; Cheng, CM; Lin, HT; Chen, WY; Chiang, PC; Lee, CC; Liao, JC; Wu, HC ; Tao, MH | BioRxiv | | | |
| 2015 | PHRF1 promotes genome integrity by modulating non-homologous end-joining. | Chang, CF; Chu, PC ; Wu, PY; Yu, MY; Lee, JY; Tsai, MD; Chang, MS | Cell death & disease 6, e1716 | | | |
| 2011 | Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR | Huang, TC; Chang, HY; Chen, CY; Wu, PY; Lee, H; Liao, YF; Hsu, WM; Huang, HC; Juan, HF | FEBS LETTERS 585, 3582-3586 | | | |
| 2012 | Structural Delineation of MDC1-FHA Domain Binding with CHK2-pThr68 | Wu, HH; Wu, PY; Huang, KF ; Kao, YY; Tsai, MD | Biochemistry 51(2), 575-577 | | | |
| 2008 | Structure and Function of the Phosphothreonine-Specific FHA Domain | Mahajan, A; Yuan, C; Lee, H; Chen, ES; Wu, PY; Tsai, MD | Science Signaling 1(51), re12. | | | |
| 2015 | The RNA recognition motif of NIFK is required for rRNA maturation during cell cycle progression | Pan, WA; Tsai, HY; Wang, SC; Hsiao, M; Wu, PY; Tsai, MD | RNA Biology 12(3), 255-267 | | | |
| 2010 | Treatment of hepatocellular carcinoma with adeno-associated virus encoding interleukin-15 superagonist. | Chang, CM; Lo, CH; Shih, YM; Chen, Y; Wu, PY; Tsuneyama, K; Roffler, SR; Tao, MH | Human gene therapy 21(5), 611-621 | | | |
| 2012 | Use of RNA Interference to Modulate Liver Adenoma Development in A Murine Model Transgenic for Hepatitis B Virus | Chen, CC; Chang, CM; Sun, CP ; Yu, CP; Wu, PY; Jeng, KS ; Hu, CP; Chen, PJ; Wu, JC; Shih, CH; Gershwin, ME; Tao, MH | Gene Therapy 19(1), 25-33 | | | |
| 1994 | 台北市八十學年度國中新生的節食意向研究－理性行動理論的應用 (Dieting intention in the seventh graders in Taipei city, 1991: an application of the theory of reasoned action) | Lee, L; Chen, CH; Wu, PY; Pan, WH | 中華公共衛生雜誌第13卷5期, 頁 419-431 | | | |
